Clinical

ba0001op1 | Clinical

Does vitamin D status impact on hip fracture incidence?: evidence of fracture variation with latitude and season in Sweden

ba0001op2 | Clinical

Meta-analysis of the effects of vitamin D supplements on bone mineral density in adults

ba0001op3 | Clinical

The risk of fractures in cirrhosis and chronic pancreatitis. a danish nationwide retrospective matched cohort study

ba0001op4 | Clinical

Relationship between bone mineral density, body composition, skin sclerosis, and serum 25(OH) vitamin D levels in systemic sclerosis

ba0001op5 | Clinical

Abstract unavailable

ba0001op6 | Clinical

Cortical and trabecular alterations in patients with bone marrow edema of the lower limb

ba0001op7 | Clinical

Bone marrow fat is metabolically distinct fat depot

ba0001op8 | Clinical

Genome-wide association study meta-analysis identifies the SOAT1/AXDND1 locus to be associated with hip and forearm fracture risk

ba0001op9 | Clinical

A genomic and transcriptomic approach to the high bone mass phenotype: evidences of heterogeneity and of additive effects of TWIST1, IL6R, DLX3, and PPARG

ba0001op10 | Clinical

Regional heterogeneity of trabecular bone microdamage density in association with trabecular microarchitecture and bone resorption in whole human lumbar vertebrae

ba0001op11 | Clinical

Health economic consequences of fractures in patients with osteoporosis: a national register based study of total and incremental health costs following fracture

ba0001op12 | Clinical

Fracture risk assessment in a primary care population: case finding using routine GP data, FRAX^® And RAIDR^® in the United Kingdom

ba0001op13 | Clinical

Hip fracture trends in Denmark 1980–2010 with age-period-cohort-effects

ba0001op14 | Clinical

Impact of hip fracture on mortality and life expectancy

ba0001op15 | Clinical

Fracture risk among men, in relation to osteopenia and osteoporosis defined by areal bone mineral density

ba0001op16 | Clinical

Long-term effects of symptomatic vs intensive bisphosphonate therapy for Paget's disease of bone: the PRISM-EZ study

ba0001op17 | Clinical

Denosumab is associated with progressive improvements in hip cortical mass and thickness

ba0001op18 | Clinical

Effects of odanacatib on BMD and safety in the treatment of osteoporosis in postmenopausal women previously treated with alendronate- a randomized placebo-controlled trial

ba0001op19 | Clinical

Effects of sclerostin antibody and maintenance of new bone induced by sclerostin antibody in animal models

ba0001op20 | Clinical

Bone Abstracts

European Calcified Tissue Society Congress 2013

Oral Posters

Does vitamin D status impact on hip fracture incidence?: evidence of fracture variation with latitude and season in Sweden

Meta-analysis of the effects of vitamin D supplements on bone mineral density in adults

The risk of fractures in cirrhosis and chronic pancreatitis. a danish nationwide retrospective matched cohort study

Relationship between bone mineral density, body composition, skin sclerosis, and serum 25(OH) vitamin D levels in systemic sclerosis

Abstract unavailable

Cortical and trabecular alterations in patients with bone marrow edema of the lower limb

Bone marrow fat is metabolically distinct fat depot

Genome-wide association study meta-analysis identifies the SOAT1/AXDND1 locus to be associated with hip and forearm fracture risk

A genomic and transcriptomic approach to the high bone mass phenotype: evidences of heterogeneity and of additive effects of TWIST1, IL6R, DLX3, and PPARG

Regional heterogeneity of trabecular bone microdamage density in association with trabecular microarchitecture and bone resorption in whole human lumbar vertebrae

Health economic consequences of fractures in patients with osteoporosis: a national register based study of total and incremental health costs following fracture

Fracture risk assessment in a primary care population: case finding using routine GP data, FRAX^® And RAIDR^® in the United Kingdom

Hip fracture trends in Denmark 1980–2010 with age-period-cohort-effects

Impact of hip fracture on mortality and life expectancy

Fracture risk among men, in relation to osteopenia and osteoporosis defined by areal bone mineral density

Long-term effects of symptomatic vs intensive bisphosphonate therapy for Paget's disease of bone: the PRISM-EZ study

Denosumab is associated with progressive improvements in hip cortical mass and thickness

Effects of odanacatib on BMD and safety in the treatment of osteoporosis in postmenopausal women previously treated with alendronate- a randomized placebo-controlled trial

Effects of sclerostin antibody and maintenance of new bone induced by sclerostin antibody in animal models

Resolution of effects on bone turnover markers and bone mineral density after discontinuation of long-term bisphosphonate use

BiosciAbstracts